BioAtla, Inc., a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics, announced that it has entered into...
BC Platforms (BCP), a global leader in healthcare data management and analytics, announced a new clinical collaboration with the Colorado Center for Personalized Medicine...
